North America Digital Dose Inhaler Market Size & Outlook

The digital dose inhaler market in North America is expected to reach a projected revenue of US$ 22,190.7 million by 2030. A compound annual growth rate of 18% is expected of North America digital dose inhaler market from 2024 to 2030.
Revenue, 2023 (US$M)
$6,967.2
Forecast, 2030 (US$M)
$22,190.7
CAGR, 2024 - 2030
18%
Report Coverage
North America

North America digital dose inhaler market, 2018-2030 (US$M)

North

North America digital dose inhaler market highlights

  • The North America digital dose inhaler market generated a revenue of USD 6,967.2 million in 2023.
  • The market is expected to grow at a CAGR of 18% from 2024 to 2030.
  • In terms of segment, dry powdered inhalers (dpis) was the largest revenue generating product in 2023.
  • Dry Powdered Inhalers (DPIs) is the most lucrative product segment registering the fastest growth during the forecast period.


North America data book summary

Market revenue in 2023USD 6,967.2 million
Market revenue in 2030USD 22,190.7 million
Growth rate18% (CAGR from 2023 to 2030)
Largest segmentDry powdered inhalers (dpis)
Fastest growing segmentDry Powdered Inhalers (DPIs)
Historical data covered2018 - 2022
Base year for estimation2023
Forecast period covered2024 - 2030
Quantitative unitsRevenue in USD million
Market segmentationDry Powdered Inhalers (DPIs)
Key market players worldwide3M Co, AstraZeneca PLC, Novartis AG ADR, ResMed Inc, OPKO Health Inc, Teva Pharmaceutical Industries Ltd, Beximco Pharmaceuticals Ltd DR, GlaxoSmithKline, Glenmark Pharmaceuticals, Sensirion, Mundipharma


Other key industry trends

  • In terms of revenue, North America region accounted for 45.1% of the global digital dose inhaler market in 2023.
  • Globally, North America is projected to lead the regional market in terms of revenue in 2030.
  • Asia Pacific is the fastest growing regional market and is projected to reach USD 10,434.2 million by 2030.

No credit card required*

Horizon in a snapshot

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more

Digital Dose Inhaler Market Scope

Digital dose inhaler market segmentation & scope
Dry Powdered Inhalers (DPIs)
Metered Dose Inhalers (MDIs)
Countries
U.S.
Canada
Germany
France
Italy
Spain
Switzerland
Netherlands
Denmark
Sweden
Norway
Japan
China
India
Australia
South Korea
Indonesia
Thailand
Mexico
Brazil
South Africa
Saudi Arabia
UK
Argentina
UAE
Kuwait

Digital Dose Inhaler Market Companies

Name Profile # Employees HQ Website

North America digital dose inhaler market outlook

The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to digital dose inhaler market will help companies and investors design strategic landscapes.


Dry powdered inhalers (dpis) was the largest segment with a revenue share of 100% in 2023. Horizon Databook has segmented the North America digital dose inhaler market based on dry powdered inhalers (dpis) covering the revenue growth of each sub-segment from 2018 to 2030.


Reasons to subscribe to North America digital dose inhaler market databook:

  • Access to comprehensive data: Horizon Databook provides over 1 million market statistics and 20,000+ reports, offering extensive coverage across various industries and regions.
  • Informed decision making: Subscribers gain insights into market trends, customer preferences, and competitor strategies, empowering informed business decisions.
  • Cost-Effective solution: It's recognized as the world's most cost-effective market research database, offering high ROI through its vast repository of data and reports.
  • Customizable reports: Tailored reports and analytics allow companies to drill down into specific markets, demographics, or product segments, adapting to unique business needs.
  • Strategic advantage: By staying updated with the latest market intelligence, companies can stay ahead of competitors, anticipate industry shifts, and capitalize on emerging opportunities.

Target buyers of North America digital dose inhaler market databook

  • Our clientele includes a mix of digital dose inhaler market companies, investment firms, advisory firms & academic institutions.
  • 30% of our revenue is generated working with investment firms and helping them identify viable opportunity areas.
  • Approximately 65% of our revenue is generated working with competitive intelligence & market intelligence teams of market participants (manufacturers, service providers, etc.).
  • The rest of the revenue is generated working with academic and research not-for-profit institutes. We do our bit of pro-bono by working with these institutions at subsidized rates.

Horizon Databook provides a detailed overview of continent-level data and insights on the North America digital dose inhaler market , including forecasts for subscribers. This continent databook contains high-level insights into North America digital dose inhaler market from 2018 to 2030, including revenue numbers, major trends, and company profiles.

Partial client list

  • logo

North America digital dose inhaler market

Sign up - it's easy, and free!

Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our free plan indefinitely.

Explore all plans

Included in Horizon account

  • 30K+ Global Market Reports
  • 120K+ Country Reports
  • 1.2M+ Market Statistics
  • 200K+ Company Profiles
  • Industry insights and more